SSII · Nasdaq · CIK 0001676163
SS Innovations International, Inc.
SS Innovations International, Inc.’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 26, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $42.5M and net income of -$12.1M, according to its XBRL data on EDGAR. Its EDGAR record lists 24 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- SS Innovations International, Inc.
- Ticker
- SSII
- SEC Central Index Key (CIK)
- 0001676163
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus (code 3841)
- Business address
- GURUGRAM
- State or country of incorporation
- FL
- Fiscal year ends
- December 31
- SEC filer category
- Non-accelerated filer<br>Smaller reporting company
- Position in SEC ticker list
- #2940 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from SS Innovations International, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Dec 31, 2021 | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | — | $1.4M | $5.9M | $20.6M | $42.5M |
| Net income | -$1.5M | -$3.2M | -$20.9M | -$19.2M | -$12.1M |
| Diluted EPS | -$0.05 | -$0.03 | -$0.14 | -$0.11 | -$0.06 |
| Total assets | $428.6K | $7.0M | $31.5M | $42.4M | $74.2M |
| Cash and equivalents | $405.8K | $217.2K | $2.0M | $466.5K | $3.2M |
XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
Recent SEC filings
The 40 newest documents filed by or about SS Innovations International, Inc., by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 26, 2026 | 8-K | Other events· period Oct 26, 2026 | Document · Index |
| Oct 13, 2026 | 8-K | Other events· period Oct 13, 2026 | Document · Index |
| Oct 13, 2026 | 8-K | Material agreement; New financial obligation· period Oct 9, 2026 | Document · Index |
| Oct 9, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026 | Document · Index |
| Oct 9, 2026 | 424B5 | PROSPECTUS SUPPLEMENT | Document · Index |
| Oct 5, 2026 | 8-K | Regulation FD disclosure· period Oct 5, 2026 | Document · Index |
| Sep 10, 2026 | 8-K | Other events· period Sep 10, 2026 | Document · Index |
| Sep 9, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 4, 2026 | Document · Index |
| Aug 26, 2026 | 8-K | Director or officer change· period Aug 21, 2026 | Document · Index |
| Aug 14, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026 | Document · Index |
| Aug 13, 2026 | 8-K | Results of operations; Regulation FD disclosure· period Aug 13, 2026 | Document · Index |
| Aug 13, 2026 | 10-Q | QUARTERLY REPORT· period Jun 30, 2026 | Document · Index |
| Aug 4, 2026 | 3 | Initial statement of beneficial ownership· period Aug 3, 2026 | Document · Index |
| Jul 17, 2026 | 8-K | Other events· period Jul 17, 2026 | Document · Index |
| Jul 14, 2026 | 8-K | Director or officer change· period Jul 14, 2026 | Document · Index |
| Jul 7, 2026 | 8-K | Other events· period Jul 7, 2026 | Document · Index |
| Jun 30, 2026 | 8-K | Other events· period Jun 30, 2026 | Document · Index |
| Jun 18, 2026 | 8-K | Material agreement· period Jun 18, 2026 | Document · Index |
| Jun 18, 2026 | 424B5 | PROSPECTUS SUPPLEMENT | Document · Index |
| Jun 15, 2026 | 8-K | Regulation FD disclosure· period Jun 15, 2026 | Document · Index |
| Jun 8, 2026 | S-8 | REGISTRATION STATEMENT | Document · Index |
| Jun 4, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 4, 2026 | Document · Index |
| Jun 4, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 4, 2026 | Document · Index |
| Jun 4, 2026 | 8-K | Other events· period Jun 4, 2026 | Document · Index |
| Jun 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 1, 2026 | Document · Index |
| May 26, 2026 | 8-K | Director or officer change· period May 18, 2026 | Document · Index |
| May 20, 2026 | 424B5 | PROSPECTUS | Document · Index |
| May 18, 2026 | EFFECT | EFFECT | Document · Index |
| May 13, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 12, 2026 | Document · Index |
| May 13, 2026 | CORRESP | CORRESP | Document · Index |
| May 13, 2026 | 8-K | Results of operations; Regulation FD disclosure· period May 13, 2026 | Document · Index |
| May 13, 2026 | 10-Q | QUARTERLY REPORT· period Mar 31, 2026 | Document · Index |
| May 8, 2026 | UPLOAD | UPLOAD | Document · Index |
| May 7, 2026 | 8-K | Other events· period May 7, 2026 | Document · Index |
| May 5, 2026 | 8-K | Other events· period May 5, 2026 | Document · Index |
| May 4, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| May 1, 2026 | S-3 | REGISTRATION STATEMENT | Document · Index |
| Apr 23, 2026 | 8-K | Regulation FD disclosure· period Apr 23, 2026 | Document · Index |
| Apr 20, 2026 | RW | WITHDRAWAL REQUEST | Document · Index |
| Apr 15, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Apr 14, 2026 | Document · Index |
Insider filing activity
24 Form 4 filings appear in SS Innovations International, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Surgical & Medical Instruments & Apparatus
- SYK STRYKER CORP
- MMM 3M CO
- BSX BOSTON SCIENTIFIC CORP
- BDX BECTON DICKINSON & CO
- MDLN Medline Inc.
- RMD RESMED INC
- DXCM DEXCOM INC
- WST WEST PHARMACEUTICAL SERVICES INC
All 51 companies in Surgical & Medical Instruments & Apparatus
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001676163 and XBRL company facts. SS Innovations International, Inc. on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement